Ari Zweiman
683 Capital Management, Llc
Assets Managed
$1.916B
Holdings
229
Last Quarter
2026 - Q1
Filed Date
17d ago
Growth Rate
-16.63%(2Q avg: 1.73%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in 683 Capital Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 229 positions.
Assets under management
The assets under management (AUM) of 683 Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.916B in assets, with a quarterly growth rate of -16.63% and a 2-quarter average growth rate of 1.73%. The portfolio is managed by Ari Zweiman, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
PLTR Palantir Technologies Inc-a
| 17.78% | $340.642M↓ Put 2.329M shares@ $146.28 avg price | |
LLY Eli Lilly & Co
| 7.16% | $137.046M 149,000 shares@ $919.77 avg price | Decreased -3.24% |
NVDA Nvidia Corp
| 4.16% | $79.526M↓ Put 456,000 shares@ $174.4 avg price | |
COF Capital One Financial Corp
| 3.58% | $68.411M 375,000 shares@ $182.43 avg price | Decreased -8.53% |
ALNY Alnylam Pharmaceuticals Inc
| 2.58% | $49.333M 149,100 shares@ $330.87 avg price | Increased 2.92% |
CVNA Carvana Co
| 2.55% | $48.729M 155,000 shares@ $314.38 avg price | Increased 3.34% |
MDGL Madrigal Pharmaceuticals Inc
| 2.46% | $47.112M↓ Put 90,000 shares@ $523.47 avg price | Decreased -9.09% |
TSLA Tesla Inc
| 2.14% | $40.892M↓ Put 110,000 shares@ $371.75 avg price | Decreased -47.61% |
ur-1⤦ Bridgebio Pharma Inc
| 2.05% | $39.242M 21.75M shares@ $1.81 avg price | |
PTGX Protagonist Therapeutics Inc
| 2.04% | $39.009M 370,100 shares@ $105.4 avg price | Decreased -14.12% |
1-10 of 229